Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
Oncolytic virotherapy (OV) is an emerging class of immunotherapeutic drugs. Their mechanism of action is two-fold: direct cell lysis and unmasking of the cancer through immunogenic cell death, which allows the immune system to recognize and eradicate tumours. Breast cancer is the most common cancer...
Main Authors: | Amy Kwan, Natalie Winder, Munitta Muthana |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/6/1128 |
Similar Items
-
From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01) -
Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies
by: Tabitha G. Cunliffe, et al.
Published: (2020-11-01) -
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
by: Qing Ji, et al.
Published: (2022-08-01) -
Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
by: Bin Zhang, et al.
Published: (2020-11-01) -
Oncolytic virotherapy for metastatic breast cancer – a case report
by: Benjamin Gesundheit, et al.
Published: (2023-06-01)